Regulatory effects of interleukin (IL)-1, interferon-β, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue

被引:89
作者
Juge-Aubry, CE
Somm, E
Chicheportiche, R
Burger, D
Pernin, A
Cuénod-Pittet, B
Quinodoz, P
Guisti, V
Dayer, JM
Meier, CA
机构
[1] Univ Hosp Geneva, Dept Internal Med, Div Endocrinol Diabet & Metab, Endocrine Unit, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Dept Internal Med, Div Immunol & Allergy, Hans Wilsdorf Lab, CH-1211 Geneva 14, Switzerland
[3] Univ Hosp Geneva, Dept Surg, Div Reconstruct Surg, Plast Reconstruct Surg Unit, CH-1211 Geneva 14, Switzerland
[4] La Tour Hosp, CH-1217 Meyrin, Switzerland
[5] Univ Lausanne Hosp, Dept Med, Div Endocrinol Diabetol & Metab, CH-1011 Lausanne, Switzerland
关键词
D O I
10.1210/jc.2003-031219
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adipose tissue is the source of production and site of action of several pro- and antiinflammatory cytokines. We have recently shown that white adipose tissue (WAT) is a major producer of the antiinflammatory IL-1 receptor antagonist (IL-1Ra). Because IL-1Ra serum levels are elevated 7-fold in human obesity and an excess of this protein has been implicated in the acquired resistance to leptin and insulin, we investigated the regulation of IL-1Ra in human WAT. We demonstrate that IL-1Ra is mainly produced by adipocytes, rather than the stromal fraction of WAT, and that IL-1alpha and beta, as well as interferon-beta(IFN-beta), strongly up-regulate the expression and secretion of IL-1Ra in WAT. Moreover, human WAT expresses the receptors and proteins known to be required for the action of IL-1 (IL-1 receptor type I, IL-1 receptor accessory protein) and IFN-beta(IFN-alpha/beta receptor subunits 1 and 2). Finally, human WAT actively secretes these regulatory cytokines, suggesting that they up-regulate IL-1Ra through a local autocrine/paracrine action, which is hypothesized to play a regulatory role in adipogenesis and metabolism.
引用
收藏
页码:2652 / 2658
页数:7
相关论文
共 27 条
[1]   Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss [J].
Bastard, JP ;
Jardel, C ;
Bruckert, E ;
Blondy, P ;
Capeau, J ;
Laville, M ;
Vidal, H ;
Hainque, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :3338-3342
[2]  
BEUTLER BA, 1985, J IMMUNOL, V135, P3969
[3]  
DELIKAT S, 1993, EXP HEMATOL, V21, P31
[4]   INTERLEUKIN-1 [J].
DINARELLO, CA .
REVIEWS OF INFECTIOUS DISEASES, 1984, 6 (01) :51-95
[5]   Association of low interleukin-10 levels with the metabolic syndrome in obese women [J].
Esposito, K ;
Pontillo, A ;
Giugliano, F ;
Giugliano, G ;
Marfella, R ;
Nicoletti, G ;
Giugliano, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) :1055-1058
[6]   STIMULATION OF LIPOLYSIS IN CULTURED FAT-CELLS BY TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1, AND THE INTERFERONS IS BLOCKED BY INHIBITION OF PROSTAGLANDIN SYNTHESIS [J].
FEINGOLD, KR ;
DOERRLER, W ;
DINARELLO, CA ;
FIERS, W ;
GRUNFELD, C .
ENDOCRINOLOGY, 1992, 130 (01) :10-16
[7]   INTERLEUKIN-1-ALPHA DECREASES THE SYNTHESIS AND ACTIVITY OF LIPOPROTEIN-LIPASE IN HUMAN ADIPOSE-TISSUE [J].
FRIED, SK ;
APPEL, B ;
ZECHNER, R .
HORMONE AND METABOLIC RESEARCH, 1993, 25 (02) :129-130
[8]   Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid [J].
Fried, SK ;
Bunkin, DA ;
Greenberg, AS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :847-850
[9]   Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes [J].
Gabay, C ;
Dreyer, MG ;
Pellegrinelli, N ;
Chicheportiche, R ;
Meier, CA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :783-791
[10]   INTERLEUKIN-1 STIMULATES GLUCOSE-TRANSPORT IN RAT ADIPOSE-CELLS - EVIDENCE FOR RECEPTOR DISCRIMINATION BETWEEN IL-1-BETA AND IL-1-ALPHA [J].
GARCIAWELSH, A ;
SCHNEIDERMAN, JS ;
BALY, DL .
FEBS LETTERS, 1990, 269 (02) :421-424